Amgen buys KAI Pharmaceuticals for $315mm in cash
Amgen Inc. has agreed to acquire private biotech KAI Pharmaceuticals Inc. for $315mm in cash.
- Drug Delivery
- Acquisition of Private Biotech
- Full Acquisition
- Intra-Biotech Deal
- Payment Includes Cash for Equity
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.